EUVIMEDEUVIMED entdecken
Crossref

HTR3A Promotes Non-small Cell Lung Cancer Through the FOXH1/Wnt3A Signaling Pathway

Zeqin Wu, Jiufei Li, Minglian Zhong, Zhiyuan Xu, Mulan Yang, Chenyang Xu

Biochemical Genetics · 2025-08 · 63 (4) · 3554-3566

DOI: 10.1007/s10528-024-10872-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Genetics, online erschienen am 24.07.2024. Verfasst von Zeqin Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic Surgery Department, Ganzhou People's Hospital, 18 MeiGuan Ave, Zhanggong District, Ganzhou, 341000, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Receptors, Serotonin, 5-HT3, Wnt3A Protein. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

5-Hydroxytryptamine receptors (5-HTRs) are strongly correlated with tumor progression in various types of cancer. Despite this, the underlying mechanisms responsible for the role of 5-HTRs in non-small cell lung cancer (NSCLC) remains unclear. This study aimed to investigate the relationship between 5-hydroxytryptamine receptor 3A (HTR3A) and NSCLC development. Our findings indicated a higher distribution of HTR3A expression in NSCLC tissues when compared with normal tissues, where patients with high HTR3A levels demonstrated shorter overall survival times. In vitro analyses revealed that overexpression of HTR3A facilitated the proliferation and migration of NSCLC cell lines (A549 and NCI-H3255). Similarly, a notable acceleration of tumor growth and enhanced pulmonary tumorigenic potential were observed in HTR3A-overexpressing tumor-bearing mice. Mechanistically, upregulation of Forkhead Box H1 (FOXH1) by HTR3A led to the activation of Wnt3A/β-catenin signaling pathways, thereby promoting the development of NSCLC. Our report thus highlights the significance of the HTR3A/FOXH1 axis during tumor progression in NSCLC, proposing HTR3A as a possible diagnostic indicator and candidate target for clinical therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsReceptors, Serotonin, 5-HT3Wnt3A ProteinForkhead Transcription FactorsHumansAnimalsMiceCell ProliferationSignal TransductionCell Line, TumorFemaleWnt Signaling PathwayGene Expression Regulation, NeoplasticMaleMice, NudeA549 CellsCell Movement

Stichwörter der Autor:innen

FOXH1HTR3ANSCLCWnt signaling

Substanzen

Receptors, Serotonin, 5-HT3Wnt3A ProteinWNT3A protein, humanForkhead Transcription FactorsHTR3A protein, human

Autor:innen und Institutionen

  • Thoracic Surgery Department, Ganzhou People's Hospital, 18 MeiGuan Ave, Zhanggong District, Ganzhou, 341000, China.
  • Department of Cardiothoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Thoracic Surgery Department, Ganzhou People's Hospital, 18 MeiGuan Ave, Zhanggong District, Ganzhou, 341000, China. yml13763998516@163.com.
  • Thoracic Surgery Department, Ganzhou People's Hospital, 18 MeiGuan Ave, Zhanggong District, Ganzhou, 341000, China. Xuchenyang1973@163.com.

Zitieren

APA

Wu, Z., Li, J., Zhong, M., Xu, Z., Yang, M., & Xu, C. (2025). HTR3A Promotes Non-small Cell Lung Cancer Through the FOXH1/Wnt3A Signaling Pathway. Biochemical Genetics, 63(4), 3554-3566. https://doi.org/10.1007/s10528-024-10872-9

Vancouver

Wu Z, Li J, Zhong M, Xu Z, Yang M, Xu C. HTR3A Promotes Non-small Cell Lung Cancer Through the FOXH1/Wnt3A Signaling Pathway. Biochemical Genetics. 2025;63(4):3554-3566. doi:10.1007/s10528-024-10872-9

BibTeX
@article{Wu2025,
  author = {Wu, Zeqin and Li, Jiufei and Zhong, Minglian and Xu, Zhiyuan and Yang, Mulan and Xu, Chenyang},
  title = {HTR3A Promotes Non-small Cell Lung Cancer Through the FOXH1/Wnt3A Signaling Pathway},
  journal = {Biochemical Genetics},
  year = {2025},
  volume = {63},
  number = {4},
  pages = {3554--3566},
  doi = {10.1007/s10528-024-10872-9}
}
Kostenlos starten →